High Flow Nasal Cannula and Conventional Oxygen Therapy in the Postoperative Management of Patien… (NCT06306651) | Clinical Trial Compass
UnknownNot Applicable
High Flow Nasal Cannula and Conventional Oxygen Therapy in the Postoperative Management of Patients With Mild to Moderate Obstructive Sleep Apnea
Egypt60 participantsStarted 2024-03-16
Plain-language summary
This study aims to compare the effectiveness of conventional oxygen therapy oxygen and high-flow nasal cannula therapy on oxygen saturation (SpO2), measuring number of SpO2 drop \>4% of base line oxygen saturation (o2 desaturation index), length of the ICU stay, and the need of use supplemental continuous positive airway pressure (CPAP) support in any of the study groups in the postoperative ICU setting.
Who can participate
Age range
21 Years – 40 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age group from 21 - 40 years old.
* Both sexes.
* Mild to moderate obstructive sleep apnea (OSA) patients with STOP-BANG score less than 5.
* OSA patients undergoing non cardiac surgeries.
* Patients who will undergo scheduled elective surgeries under general anesthesia.
Exclusion Criteria:
* Patient refusal of procedure or participation in the study.
* Patients with severe OSA, STOP-BANG score more than or equal 5.
* Patients dependent on home ventilation CPAP or bilevel devices.
* Pregnant females.
* Post cardiac or thoracic surgery patients.
* More than American Society of Anesthesiologists (ASA) II patients.
* Head and face trauma patients.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Oxygen desaturation index
Timeframe: During intensive care unit stay (assessed up to day 5)